Ampio Pharmaceuticals Balance Sheet Health
Financial Health criteria checks 3/6
Ampio Pharmaceuticals has a total shareholder equity of $3.4M and total debt of $177.0K, which brings its debt-to-equity ratio to 5.3%. Its total assets and total liabilities are $5.7M and $2.4M respectively.
Key information
5.3%
Debt to equity ratio
US$177.00k
Debt
| Interest coverage ratio | n/a |
| Cash | US$4.12m |
| Equity | US$3.36m |
| Total liabilities | US$2.38m |
| Total assets | US$5.74m |
Recent financial health updates
Financial Position Analysis
Short Term Liabilities: AMPE's short term assets ($5.7M) exceed its short term liabilities ($2.4M).
Long Term Liabilities: AMPE has no long term liabilities.
Debt to Equity History and Analysis
Debt Level: AMPE has more cash than its total debt.
Reducing Debt: AMPE's debt to equity ratio has increased from 0% to 5.3% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: Insufficient data to determine if AMPE has enough cash runway based on its current free cash flow.
Forecast Cash Runway: Insufficient data to determine if AMPE has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.